The Utility of Genomic Testing for Hyperphenylalaninemia

Elisabetta Anna Tendi1, Maria Guarnaccia1, Giovanna Morello1

  • 1Institute for Biomedical Research and Innovation, National Research Council, Via Paolo Gaifami 18, 95026 Catania, Italy.

Summary

Hyperphenylalaninemia (HPA) is an amino acid disorder due to enzyme defects. Genomic testing aids in early diagnosis and personalized treatment for better patient outcomes.